Literature DB >> 6883807

Cell-mediated immune response to respiratory syncytial virus infection in owl monkeys.

W C Koff, F R Caplan, S Case, S B Halstead.   

Abstract

The suitability of owl monkeys as experimental models to study the cellular immune response to respiratory syncytial virus (RSV) infection was examined. Seronegative owl monkeys inoculated intranasally with RSV shed large quantities of virus and developed clinically evident upper respiratory disease. RSV infected monkeys had significant lymphoproliferative responses to RSV antigen by 4 weeks post-infection. In contrast, no positive blastogenic responses were elicited during the acute phase of illness. An in vitro 51Cr release assay was developed to study owl monkey antibody-dependent cellular cytoxicity (ADCC) against RSV infected Hep-2 cells. Peripheral blood mononuclear cells from owl monkeys in the presence of RSV specific antibody caused lysis of RSV infected target cells. The effector cell for ADCC was found to be non-adherent to plastic. The owl monkey RSV ADCC system was found to closely parallel RSV specific ADCC observed with human effector cells. In addition, it was found that heterologous matches of human effector cells with monkey sera and monkey effector cells with human sera were equally efficient in mediating RSV specific ADCC. These studies demonstrate the value of the owl monkey as a model to study the pathogenesis or RSV infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6883807      PMCID: PMC1535688     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION.

Authors:  R M CHANOCK; R H PARROTT
Journal:  Pediatrics       Date:  1965-07       Impact factor: 7.124

2.  The isolation of respiratory syncytial virus from children with acute respiratory disease.

Authors:  A HOLZEL; L PARKER; W H PATTERSON; L L WHITE; K M THOMPSON; J O TOBIN
Journal:  Lancet       Date:  1963-02-09       Impact factor: 79.321

3.  An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

Authors:  A Z Kapikian; R H Mitchell; R M Chanock; R A Shvedoff; C E Stewart
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

Review 4.  Virus infections and respiratory disease of childhood.

Authors:  P S Gardner
Journal:  Arch Dis Child       Date:  1968-12       Impact factor: 3.791

5.  Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

Authors:  J Mills; J E Van Kirk; P F Wright; R M Chanock
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

6.  Respiratory syncytial virus infection in inbred mice.

Authors:  G A Prince; R L Horswood; J Berndt; S C Suffin; R M Chanock
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

Review 7.  Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.

Authors:  K McIntosh; J M Fishaut
Journal:  Prog Med Virol       Date:  1980

8.  An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test.

Authors:  H V Coates; D W Alling; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-03       Impact factor: 4.897

9.  In vitro migration of human alveolar macrophages: effects of cigarette smoking.

Authors:  G A Warr; R R Martin
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

10.  Reactivity of monoclonal antibodies against human leucocyte antigens with lymphocytes of non-human primate origin.

Authors:  R H Neubauer; R Levy; B C Strnad; H Rabin
Journal:  J Immunogenet       Date:  1981-12
View more
  3 in total

Review 1.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.

Authors:  Xiaoyan Zhan; Karen S Slobod; Bart G Jones; Robert E Sealy; Toru Takimoto; Kelli Boyd; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Int Immunol       Date:  2014-12-04       Impact factor: 4.823

3.  Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

Authors:  Bart G Jones; Robert E Sealy; Sherri L Surman; Allen Portner; Charles J Russell; Karen S Slobod; Philip R Dormitzer; John DeVincenzo; Julia L Hurwitz
Journal:  Vaccine       Date:  2014-04-14       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.